Loading...
Market
Will Stanford's cancer cell self-destruction method enter human trials by end of 2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Public announcements from Stanford Medicine or clinical trial registries
Story
Stanford Scientists Develop Novel Method to Induce Cancer Cell Self-Destruction
Nov 4, 2024, 12:03 PM
Scientists have discovered a novel method to induce self-destruction in cancer cells. Stanford researchers at Stanford Medicine have developed a technique that involves gluing two proteins together, which flips the normal action of a lymphoma protein from preventing cell death to triggering it. This advancement is part of broader efforts in genomics, where RNA molecules are designed to specifically target genes and pathways in cancer cells. Additionally, a new study by Professor Shachar Idit's team has shown that blocking 'molecular bridges' created by cancerous tumors can restore immune attacks and slow the progression of cancer.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Successful with significant results • 25%
Moderate success with some positive results • 25%
No significant results • 25%
Trial halted or inconclusive • 25%
